This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Breast cancer cells (MDA-MB-231)
Colon cancer cell (SW48)
Leukemia cell (K562)
Mammary gland cells (MCF10A)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Multiple myeloma cells (U266)
Plasma
Serum
By sample status
Electroporated with Dicer antibody
Hypoxic condition (24 hr)
Multiple myeloma patients
Normal
Normal_Exiqon
Normal_old
Sample A_Illumina
Sample B_NEB
Sample C_NEB
Survived under long-term hypoxia
Transplant islets into mouse xenotransplantation-rejected
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-490-3p
MIMAT0002806
0.0e+0
4.8e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
4.8e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
4.8e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
5.7e-2
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
9.7e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
1.1e-3
1.1e-3
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
1.1e-12
4.6e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
1.7e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
1.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
5.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
1.4e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
0.0e+0
1.4e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000229_2
20
/
0
/
20
mmu-miR-490-3p
MIMAT0003780
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000229_2
20
/
0
/
20
rno-miR-490-3p
MIMAT0012823
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000229_2
20
/
0
/
20
hsa-miR-490-3p
MIMAT0002806
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000229_2
20
/
0
/
20
[1]